Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Risk factors for pulmonary hypertension identified in lupus patients
Specific autoantibodies could help to prognosticate the development of PAH and its prognosis.
News
Radiographic progression in axial spondyloarthritis moves slowly in first 5 years
The net percentage of patients who progressed was 5%, calculated as those who went from nonradiographic axSpA to radiographic axSpA minus those...
Video
VIDEO: Triple therapy study and new recommendations provide guidance on CAPS
MADRID – New data confirm that triple therapy with anticoagulation, corticosteroids, and plasma exchange or intravenous immunoglobulins increases...
News
Sacroiliac structural changes show on MRI in nonradiographic axial SpA despite no inflammation
A study lends evidence for justifying earlier treatment with biologics for some patients.
News
FDA approves first new drug for ALS in decades
Edaravone (Radicava) is only the second drug ever to be approved by the agency for amyotrophic lateral sclerosis.
Video
VIDEO: Big research trials at AAN bring up important cost decisions
BOSTON – How will neurologists strike a balance between new drugs’ improved efficacy and safety and their affordability for patients?
News
VIDEO: Pilot stem cell trial for multiple system atrophy shows promising results
BOSTON – How might intrathecally–administered mesenchymal stem cells affect multiple system atrophy treatment?
News
Sepsis survivors may have high risk for seizures
BOSTON – Survivors of sepsis face a significantly increased risk of seizures following an index hospitalization, regardless of any previous...
News
Neurologists weigh in on rising drug prices
Neurologists will tackle the issues surrounding rising prices for neurological drug treatments in a set of presentations during the annual meeting...
News
Ocrelizumab gets first-ever FDA approval for primary progressive MS
The humanized monoclonal antibody ocrelizumab became the first drug to receive approval from the Food and Drug Administration for the treatment of...
News
Methotrexate use justified for early RA, disease prevention
Rheumatoid arthritis prevention seems possible with intervention using a drug such as methotrexate for high-risk individuals.
News
Opinions vary considerably on withdrawing drugs in clinically inactive JIA
There’s no one way to stop or taper medications for young patients with clinically inactive JIA.
News
Lyme arthritis changes its immune response profile if it persists after antibiotics
The persistence of Lyme arthritis after treatment with antibiotics comes with a shift from an immune response expected for bacterial infection to...
Article
New histopathologic marker may aid dermatomyositis diagnosis
The detection of sarcoplasmic myxovirus resistance A expression in immunohistochemical analysis of muscle biopsy in patients suspected of having...
Article
When primary anti-TNF fails in axial spondyloarthritis, consider comorbidities or second anti-TNF
A second TNFi may be useful in axSpA patients with primary inefficacy to their first TNFi, but also consider the impact of painful comorbidities...